Literature DB >> 16173011

Molecular epidemiology of the hepatitis C virus in Western Siberia.

A V Shustov1, G V Kochneva, G F Sivolobova, A A Grazhdantseva, I V Gavrilova, L A Akinfeeva, I G Rakova, M V Aleshina, V N Bukin, V G Orlovsky, V S Bespalov, B H Robertson, S V Netesov.   

Abstract

Western Siberia is the region with little information on the prevalence of hepatitis C virus (HCV) infection, genotypic diversity of HCV isolates and risk factors. A molecular epidemiological survey was conducted to clarify these issues. Four groups of volunteers were included in a cross-sectional study (n = 500 in each group): health care workers; daycare patients from a hospital for drug users, daycare patients from an AIDS prevention and control center; and persons admitted to a local general practice clinic for any reason (outpatients). The anti-HCV IgG prevalence was 4.6% in health care workers, 48.0% in a narcological center, 35.8% in AIDS center, and 5.6% in outpatients. HCV RNA was found in 79.3%-86.3% of seropositives. A total of 388 HCV isolates were genotyped by direct sequencing and phylogenetic analysis of the 5'-UTR and NS5B regions of HCV genome. The genotypes distribution was: 1b--50.3%, 2a--4.4%, 2c--0.3%, 3a--44.8%. One isolate (0.3%) could not be typed unambiguously. This genotypic diversity is intermediate between that of European Russia and China. Genotype 1 prevailed in an older age group (75% among 51-60 years old), and genotype 3 was most prevalent in young people (51.4% in 16-20 years old). A statistically significant (P < 0.05) increase in risk was found in intravenous drug users (odds ratio (OR) = 77.5), unemployed persons (OR = 16.3), persons having >4 sexual partners during lifetime (OR = 4.3), and male homosexuals (OR = 6.6). (c) 2005 Wiley-Liss, inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16173011     DOI: 10.1002/jmv.20467

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.

Authors:  Elijah Paintsil; Sergei V Verevochkin; Elena Dukhovlinova; Linda Niccolai; Russell Barbour; Edward White; Olga V Toussova; Louis Alexander; Andrei P Kozlov; Robert Heimer
Journal:  Addiction       Date:  2009-08-27       Impact factor: 6.526

3.  Risk factors for infection with different hepatitis C virus genotypes in southern Brazil.

Authors:  Marisa Lúcia Romani Paraboni; Marina Dallagasperina Sbeghen; Fernando Herz Wolff; Leila Beltrami Moreira
Journal:  ScientificWorldJournal       Date:  2012-05-22

4.  Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context.

Authors:  V S Kichatova; K K Kyuregyan; N V Soboleva; A A Karlsen; O V Isaeva; M G Isaguliants; M I Mikhailov
Journal:  J Immunol Res       Date:  2018-02-07       Impact factor: 4.818

5.  Introduction to molecular virology.

Authors:  S V Netesov; N A Markovich
Journal:  Russ J Genet Appl Res       Date:  2014-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.